Company profile
Bioceltix
Bioceltix is changing the veterinary therapy standards. We develop innovative biopharmaceuticals based on stem cells.
- Industry
- Biotechnology Research
- Employees
- 45
- Headquarters
- Wrocław, Woj. Dolnośląskie
- LinkedIn followers
- 5,284
- Office locations
- 1
Bioceltix company summary
Bioceltix is a company in the Biotechnology Research industry, headquartered in Wrocław, Woj. Dolnośląskie. On LinkedIn the company has around 45 employees and 5,284 followers. Warmrank detected 19 technologies across 15 categories on bioceltix.com, including Apache HTTP Server, Elementor, GetResponse. Its listed specialties include biotechnology, biopharma, vet therapy, stem cell-based, new pharma.
What technology does Bioceltix use?
Warmrank detected 19 technologies on bioceltix.com, last checked July 2026. Click any tool to see other companies that use it.
Miscellaneous
HTTP/3
Open Graph
RSSJavaScript libraries
jQuery
jQuery Migrate
JetEngine
WPML
WordPressCookie compliance
Moove GDPR ConsentDatabases
MySQLFont scripts
Google Font APIMarketing automation
GetResponsePage builders
ElementorPerformance
Priority HintsProgramming languages
PHP
Yoast SEOWeb servers
Apache HTTP ServerWebmail
Microsoft 365WordPress themes
Hello ElementorAbout Bioceltix
Bioceltix is a Wrocław-based and internationally oriented biotechnological company developing innovative, both stem cells and secretome based products, for companion animals. Our flagship technology for manufacturing biopharmaceuticals for veterinary use utilizes the therapeutic potential of allogeneic stem cells (one donor – many recipients). Owning a GMP production facility, we provide single technology for several species, diseases, and routes of administration. Our cutting-edge approach will allow the product to be batch-produced and ready for off-the-shelf sale. The veterinary medicines, based on the immunomodulatory mechanism of action of MSC, will be an alternative to the symptomatic pharmacotherapy focused mainly on alleviating pain and inflammation. Our goal is to create analgesic and anti-inflammatory biopharmaceuticals that will induce the natural mechanisms of regenerating tissues affected by the disease. In our pipeline we have products intended for the treatment of atopic dermatitis and osteoarthritis in dogs and of osteoarthritis in horses – all in the advanced development stage. The registration procedure for BCX-CM-J and BCX-EM in the European Medicines Agency has been launched. We are led by the motto: “More than animal. More than technology.”
Specialties
Where is Bioceltix located?
Bioceltix lists 1 location.
Compare companies similar to Bioceltix
More companies in Biotechnology Research.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
Bioceltix bioceltix.com | Biotechnology Research | 45 | - | Wrocław, Woj. Dolnośląskie |
 Thermo Fisher Scientific thermofisher.com | Biotechnology Research | 100,779 | - | Waltham, MA |
 Amgen amgen.com | Biotechnology Research | 41,028 | 1980 | Thousand Oaks, CA |
 Biogen biogen.com | Biotechnology Research | 7,742 | - | Cambridge, MA |
 Biocon biocon.com | Biotechnology Research | 11,902 | - | Bangalore, Karnataka |
| Biotechnology Research | 28,679 | - | Bethesda, MD | |
 Genentech gene.com | Biotechnology Research | 18,296 | 1976 | South San Francisco, California |
 Eurofins eurofins.com | Biotechnology Research | 24,928 | - | Luxembourg, Luxembourg |
 Gilead Sciences gilead.com | Biotechnology Research | 14,743 | - | Foster City, CA |
 Syneos Health syneoshealth.com | Biotechnology Research | 23,772 | - | Morrisville, NC |
 Moderna modernatx.com | Biotechnology Research | 6,238 | 2010 | Cambridge, Massachusetts |
Frequently asked questions about Bioceltix
What does Bioceltix do?
Bioceltix is a Wrocław-based and internationally oriented biotechnological company developing innovative, both stem cells and secretome based products, for companion animals. Our flagship technology for manufacturing biopharmaceuticals for veterinary use utilizes the therapeutic potential of allogeneic stem cells (one donor – many recipients). Owning a GMP production facility, we provide single technology for several species, diseases, and routes of administration. Our cutting-edge approach will allow the product to be batch-produced and ready for off-the-shelf sale. The veterinary medicines, based on the immunomodulatory mechanism of action of MSC, will be an alternative to the symptomatic pharmacotherapy focused mainly on alleviating pain and inflammation. Our goal is to create analgesic and anti-inflammatory biopharmaceuticals that will induce the natural mechanisms of regenerating tissues affected by the disease. In our pipeline we have products intended for the treatment of atopic dermatitis and osteoarthritis in dogs and of osteoarthritis in horses – all in the advanced development stage. The registration procedure for BCX-CM-J and BCX-EM in the European Medicines Agency has been launched. We are led by the motto: “More than animal. More than technology.”
What technology does Bioceltix use?
Warmrank detected 19 technologies on bioceltix.com, including Apache HTTP Server, Elementor, GetResponse, Google Font API, HTTP/3, Hello Elementor, JetEngine, Microsoft 365.
How many employees does Bioceltix have?
Bioceltix has around 45 employees on LinkedIn.
Where is Bioceltix headquartered?
Bioceltix is headquartered in Wrocław, Woj. Dolnośląskie.
Build a lead list from companies like Bioceltix
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.